Expert Roundtable Discussion on Penile Prosthesis Infection Prevention Measures

Roundtable Discussion

Five experts respected for their work in the development of animal models of alcohol craving offer their perspectives in a roundtable discussion format. The panel members discuss the various definitions and theories of alcohol craving and the benefits and limitations of using animal models to study alcohol craving in humans. Animal models have helped further the understanding of craving by prov...

A Roundtable Discussion 3

Mechanism of Penile Prosthesis Induced Urethral Stricture: Treatment and Prevention

The advent of phosphodiesterase type 5 inhibitor has revolutionized the management of erectile dysfunction (ED). Since the introduction of sildenafil citrate in 1998, oral systemic therapy has become the first line therapy for men with ED. However, oral pharmacotherapy often fails in patients with severe diabetes, radical prostatectomy, Peyronie’s disease, and severe penile fibrosis. These pati...

The Prevention and Treatment of Penile Prosthesis Infections

Since they introduction in the treatment of erectile dysfunction (ED), phosphodiesterase type 5 (PDE-5) inhibitors have achieved widespread acceptance. Today PDE-5 inhibitors are considered as first-line oral pharmacotherapy in the management of ED (Hatzimouratidis et al., 2010). However, penile implants are still a popular choice, especially in patients who have failed to achieve erections by ...

Disease state awareness in Gaucher disease: a Q&A expert roundtable discussion.

Gaucher disease is an inherited lysosomal storage disorder caused by mutations in the gene that encodes the lysosomal enzyme glucocerebrosidase. Inadequate enzymatic activity causes cells to become engorged due to an accumulation of glycolipids. Engorged cells then accumulate in various organs, resulting in a range of signs and symptoms. Gaucher disease occurs worldwide but is more common among...